Optometrists in Vega Alta, PR Accepting Medicare
7 Optometrists found. Showing 1 - 7
 Doctor Vision Csp Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1 B Calle Estancion, Local # 4, Vega Alta, PR 00692 Phone: 787-270-3727 |
Aecv.llc Optometrist Medicare: Medicare Enrolled Practice Location: 232 Calle Roble, Vega Alta, PR 00692 Phone: 787-390-6337 |
 Dr. Wilfredo Rosado-maldonado, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: Calle Luis Munoz Rivera 58-a, Vega Alta, PR 00692 Phone: 787-883-6406 Fax: 787-883-7142 |
 Dr. Alma Latoni Benedetti, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: Centro Gran Caribe Mall, Vega Alta, PR 00692 Phone: 787-883-1414 Fax: 787-883-1414 |
J & F Optical Service Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: Carr # 2 Centro Gran Caribe Mall, Vega Alta, PR 00646 Phone: 787-883-4646 |
Dr. Katherine G Rivera Hernandez, O.D Optometrist Medicare: Medicare Enrolled Practice Location: Carr 2 Km 30 Bo Espinosa, Vega Alta, PR 00692 Phone: 787-206-5686 Fax: 787-915-5058 |
Dr. Augusto E Carrion, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 232 Roble Street, Vega Alta, PR 00692 Phone: 787-390-6337 |
News Archive
FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer
The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.
Obama to meet with House Democrats Saturday
President Barack Obama's meeting with House Democrats - originally scheduled for today - is now slated for tomorrow, in advance of an expected weekend vote on the health reform bill.
RXi Pharmaceuticals receives prestigious Innovation of the Year Award
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported that the Company has received Frost & Sullivan's 2009 North American RNAi Therapeutic Design & Delivery Technology Innovation of the Year Award for the development of its proprietary RNAi compounds, rxRNA™, and advanced delivery approaches.
Clinical interventions useful in reducing reproductive coercion, unintended pregnancy: Study
Specifically asking young women during visits to family planning clinics whether their partners had attempted to force them to become pregnant - a type of intimate-partner violence called reproductive coercion - dramatically reduced the likelihood that the women would continue to experience such pressures, according to a new pilot study led by researchers at the UC Davis School of Medicine.
Bisphosphonates may be safe and beneficial for osteoarthritis patients
Bisphosphonates (a class of drugs that prevent the loss of bone density and used to treat osteoporosis and similar diseases) appear to be safe and beneficial for osteoarthritis patients.
› Verified 9 days ago
Occupational Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Physical Therapists
Podiatrists